Biochemistry, Genetics and Molecular Biology
LDL Receptor
100%
Eicosanoid Receptor
83%
Low-Density Lipoprotein
80%
Sterol
75%
Mouse
72%
Sterol Regulatory Element-Binding Protein
59%
Genetics
53%
Fibroblast
49%
Blood Pressure
49%
Enzyme
48%
Lipoprotein
45%
Familial Hypercholesterolemia
44%
Oxidoreductase
43%
Reductase
40%
Cohort Study
36%
Allele
30%
Cholesterol Synthesis
30%
Body Mass
29%
Transcription
28%
Prevalence
27%
Amino Acids
27%
Triglyceride
26%
N-Terminus
26%
Androgen Receptor
25%
HMG-CoA
25%
Messenger RNA
25%
Glomerulus Filtration
23%
Hepatocyte
23%
Lipid
22%
Secretion (Process)
22%
Surface Property
22%
Zebra Fish
22%
Adenosine Triphosphate
20%
Metabolic Pathway
20%
Homeostasis
20%
Kidney Function
20%
Receptor Gene
19%
Cell Membrane
19%
Hypercholesterolemia
19%
Leporidae
19%
Precursor
18%
Metabolite
18%
Apolipoprotein
17%
Promoter Region
17%
Natriuretic Peptide
17%
Lipogenesis
16%
Blood Level
16%
Sterol Regulatory Element Binding Protein 2
16%
Transcription Factors
16%
Exon
16%
Transgenic Mouse
16%
Systolic Blood Pressure
16%
Internalization
15%
Insulin Resistance
15%
Cysteine
15%
C-Terminus
15%
Epidermal Growth Factor Receptor
15%
Cholesteryl Ester
14%
Iodine-125
14%
Sterol Regulatory Element Binding Protein 1c
14%
Ketogenesis
13%
SREBP Cleavage Activating Protein
13%
Glucose Blood Level
13%
ABCG5
13%
Fibroblast Growth Factor 23
13%
Farnesyltransferase
13%
Protease
12%
Fatty Acid Synthesis
12%
Isoform
12%
Glucocorticoid
12%
Carcinogenesis
12%
Copurification
12%
Sodium-Hydrogen Antiporter
12%
Endocytosis
12%
ABCG8
12%
Cell Culture
12%
Clinical Trial
11%
Lipoprotein Blood Level
11%
Cholesterol Blood Level
11%
All Cause Mortality
11%
Regulatory Element
10%
Cholesterol Level
10%
Kinase
10%
Phosphotransferase
10%
Genome-Wide Association Study
10%
Acyltransferase
10%
N-Acetyltransferase
10%
Single-Nucleotide Polymorphism
10%
Intron
10%
Genetic Epidemiology
10%
Cisplatin
10%
Absorption
10%
Malonyl-CoA
10%
Sterol Regulatory Element Binding Protein 1
9%
Binding Site
9%
Normal Human
9%
Wild Type
9%
Knockout Mouse
9%
Chinese Hamster
9%
Beta Oxidation
9%
Medicine and Dentistry
Chronic Kidney Disease
88%
Disease
76%
Non Small Cell Lung Cancer
63%
Cohort Analysis
51%
Neoplasm
48%
Oncology
45%
Malignant Neoplasm
44%
Prevalence
42%
Cardiovascular Disease
35%
Idiopathic Thrombocytopenic Purpura
34%
Sickle-Cell Disease
33%
Small Cell Lung Cancer
33%
Infection
32%
Blood Pressure
32%
Pylorus
31%
Brain Ischemia
31%
Radiation Therapy
31%
Cisplatin
29%
Cardiovascular System
28%
Gastritis
26%
Acute Lymphoblastic Leukemia
25%
Biopsy
24%
Helicobacter Pylori
24%
Helicobacter Infection
24%
Etoposide
23%
Biological Marker
23%
Apoplexy
22%
Odds Ratio
21%
Germinoma
21%
Diabetes
19%
Stomach Cancer
19%
Paclitaxel
19%
Lung Cancer
19%
Sodium Ion
18%
Pediatrics
18%
Heart Failure
18%
Drug Therapy
18%
Glomerular Filtration Rate
18%
Body Mass Index
18%
Bleeding
17%
Pathologist
17%
Diagnosis
17%
Epileptic Absence
17%
Carboplatin
16%
Kidney Function
16%
Childhood Cancer
16%
Low-Density Lipoprotein
16%
Systolic Blood Pressure
15%
Arm
15%
Clinical Trial
15%
Surgery
15%
LDL Receptor
15%
Hazard Ratio
14%
Cardiovascular Risk
14%
Platelet
14%
Overall Survival
14%
Sodium Bicarbonate
13%
Intestinal Metaplasia
13%
Adolescent
13%
Quality of Life
13%
In Vitro
13%
Fibroblast Growth Factor 23
13%
Nephropathy
12%
Stomach Mucosa
12%
Receptor
12%
Adenosine Triphosphate
12%
Disease Exacerbation
12%
Acute Kidney Injury
11%
Myocardial Infarction
11%
Cancer
11%
Urinary System
11%
Symptom
11%
Gastroesophageal Reflux
11%
Food Allergy
11%
Lipoprotein
11%
Polyp
11%
Secretion (Process)
11%
Adverse Event
11%
Combination Chemotherapy
10%
Antihypertensive Agent
10%
Neonate
10%
Meta-Analysis
10%
Randomized Controlled Trial
10%
Health Care Cost
10%
Low Density Lipoprotein Cholesterol
10%
Cross Sectional Study
10%
Medicine
9%
Maturity Onset Diabetes of the Young
9%
Stomach Biopsy
9%
Hepatocyte
9%
End Stage Renal Disease
9%
Group Trial
9%
Fibroblast
9%
Atrophic Gastritis
9%
Clinician
9%
Isotopes of Calcium
9%
Phase II Trials
9%
Health System
8%
Ischemic Heart Disease
8%
Atherosclerosis
8%
Keyphrases
Low-density Lipoprotein Receptor
58%
Low-density Lipoprotein
58%
Chronic Kidney Disease
48%
Cholesterol
46%
Sterol Regulatory Element-binding protein-1c (SREBP-1c)
45%
Chronic Renal Insufficiency Cohort
40%
Non-small Cell Lung Cancer (NSCLC)
37%
Liver
34%
Acute Ischemic Stroke
34%
Confidence Interval
33%
Lipoproteins
30%
Homozygous Familial Hypercholesterolemia (HoFH)
29%
Chemotherapy
28%
Sterols
28%
Cisplatin
24%
Ischemic Stroke
21%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
21%
Blood Pressure
20%
Paclitaxel
20%
Proximal Tubule
20%
Phase II Trial
20%
Hypertension
20%
United States
19%
Etoposide
19%
Na +
18%
Body Mass Index
18%
Cardiovascular Disease
17%
Helicobacter Pylori Infection
17%
Bogalusa Heart Study
17%
Small Cell Lung Cancer
17%
Carboplatin
17%
Cardiovascular Risk
17%
Hazard Ratio
17%
Kidney Disease Progression
16%
Eastern Cooperative Oncology Group
16%
Androgen Resistance
16%
Insulin
16%
Helicobacter Pylori (H. pylori)
16%
China
15%
Endoplasmic Reticulum
15%
Cholesterol Synthesis
15%
Tumor
15%
Human Fibroblasts
15%
Androgen Receptor
13%
Heart Failure
13%
Group Studies
13%
Systolic Blood Pressure
13%
Proximal Convoluted Tubules
13%
Clinical Outcomes
13%
Risk Factors
12%
Estimated Glomerular Filtration Rate
12%
Odds Ratio
12%
Fibroblast Growth Factor 23 (FGF23)
12%
All-cause Mortality
12%
Low-density Lipoprotein Cholesterol (LDL-C)
12%
High-density Lipoprotein Cholesterol (HDL-C)
12%
125I
11%
Myocardial Infarction
11%
Germ Cell Tumor
11%
Diabetes
11%
Hamster
10%
Combination Chemotherapy
10%
LDL Receptor
10%
Major Disability
10%
Ischemic Stroke Patients
10%
Cholesterol Levels
10%
Fibroblasts
10%
Inflammation
10%
Older Adults
10%
Sickle Cell Disease
10%
Amino Acids
10%
Acute Ischemic Stroke Patients
10%
Acute Lymphoblastic Leukemia
10%
Phase II Study
10%
Monoclonal Antibody
9%
Transgenic Mice
9%
Complementary DNA (cDNA)
9%
Carboplatin-paclitaxel
9%
Atherosclerotic Cardiovascular Disease (ASCVD)
9%
Kidney
9%
Cholesteryl Ester
9%
Obesity
9%
Reductase
8%
Lipids
8%
3-hydroxy-3-methylglutaryl-CoA Reductase
8%
3-hydroxy-3-methylglutaryl-coenzyme A
8%
Resectable Lung Cancer
8%
SREBP Cleavage-activating Protein
8%
Type 2 Diabetes Mellitus (T2DM)
8%
Median Survival
8%
NHE3
8%
Glioblastoma
8%
Vascular Events
8%
Randomized Trial
8%
Multivariable
8%
Heterozygote
7%
Cardiovascular Outcomes
7%
Plasma Membrane
7%
Rat Liver
7%
Antiporter
7%